TGF-β inhibitors can inhibit the growth and multiplication of chemotherapy-resistant tumor-initiating cells (TIC) in vivo [84] forming the basis for combinatorial chemotherapy for patients suffering from TNBC. Here, TGFB1 is linked to neoplasm.